Latest Insider Transactions at Cumberland Pharmaceuticals Inc (CPIX)
This section provides a real-time view of insider transactions for Cumberland Pharmaceuticals Inc (CPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CUMBERLAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CUMBERLAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.89 P/Share
|
|
Jun 02
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.89 P/Share
|
|
Jun 01
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.94 P/Share
|
|
Jun 01
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.94 P/Share
|
|
Jun 01
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.94 P/Share
|
|
Jun 01
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.94 P/Share
|
|
May 28
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.93 P/Share
|
|
May 28
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.93 P/Share
|
|
May 28
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.93 P/Share
|
|
May 28
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.93 P/Share
|
|
May 27
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.94 P/Share
|
|
May 27
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.94 P/Share
|
|
May 27
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.94 P/Share
|
|
May 27
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.94 P/Share
|
|
May 26
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.85 P/Share
|
|
May 26
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.85 P/Share
|
|
May 26
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.85 P/Share
|
|
May 26
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.85 P/Share
|
|
May 25
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.91 P/Share
|
|
May 25
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.91 P/Share
|
|
May 25
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.89 P/Share
|
|
May 25
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.91 P/Share
|
|
May 24
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$45
$3.05 P/Share
|
|
May 24
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.05 P/Share
|
|
May 24
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$315
$3.02 P/Share
|
|
May 24
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.02 P/Share
|
|
May 21
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$45
$3.06 P/Share
|
|
May 21
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.06 P/Share
|
|
May 21
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$315
$3.06 P/Share
|
|
May 21
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.06 P/Share
|
|
May 20
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.94 P/Share
|
|
May 20
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.94 P/Share
|
|
May 20
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.94 P/Share
|
|
May 20
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.94 P/Share
|
|
May 19
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.83 P/Share
|
|
May 19
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.83 P/Share
|
|
May 19
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.83 P/Share
|
|
May 19
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.83 P/Share
|
|
May 18
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.89 P/Share
|
|
May 18
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.89 P/Share
|
|
May 18
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.91 P/Share
|
|
May 18
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.89 P/Share
|
|
May 17
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.84 P/Share
|
|
May 17
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.84 P/Share
|
|
May 17
2021
|
Michael Bonner Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct |
7,500
-39.02%
|
$15,000
$2.83 P/Share
|
|
May 17
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.84 P/Share
|
|
May 17
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,805
+1.74%
|
$11,610
$2.84 P/Share
|
|
May 14
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.81 P/Share
|
|
May 14
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.81 P/Share
|
|
May 14
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.81 P/Share
|